Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Menu Back to Global-Executive-Forum

DIA 2017: Global Executive Forum

Wednesday, June 21

DIA 2017: Driving Insights to Action!

The Global Executive Forum at the DIA 2017 Annual Meeting is your opportunity to engage with your industry, government, and academic peers from around the world and across the health care product development ecosystem. DIA invites you to join us to meet and work alongside drug and policy decision-makers to collectively identify common challenges and possible solutions. Your voice is paramount in the critical exchange of ideas that will propel efficiency and effectiveness of drug development and life cycle management.

As a Global Executive Forum participant you will:

  • Engage in an invitation-only discussion forum and luncheon with the International Coalition of Medicines Regulatory Authorities (ICMRA) leadership
  • Receive a first-hand and exclusive update on the TransCelerate Biopharma initiative
  • Participate in a round table with Clinical Research Organizations (CROs) leadership discussing the critical opportunities and challenges in drug development
  • Receive an update on the policy state-of-play in Washington, DC, as it affects our drug development ecosystem
  • Be invited to attend the exclusive President’s Reception to interact with the DIA Board, DIAmond Session speakers and other senior attendees of DIA 2017

Tuesday, June 20

  • DIA President’s Reception

    6:30-8:00PM | Normandie Lounge - Hilton Chicago, 720 South Michigan Avenue

Wednesday, June 21

  • DIAmond Session: International Regulatory Convergence

    8:00-9:30AM | Room S100a

    Chair

    • Agnès Saint-Raymond, MD, Head of International Affairs (ad interim), Head of Portfolio Board, European Medicines Agency, European Union

    Panelists

    • Jarbas Barbosa, MD, PhD, ICMRA Project Lead; Director- President, Agência Nacional De Vigilância Sanitária (ANVISA), Brazil
    • Dara Corrigan, JD, Acting Deputy Commissioner for Global Regulatory Operations and Policy, FDA
    • Ian Hudson, MD, FFPM, FRCP, Chief Executive, Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom
    • Tatsuya Kondo, MD, PhD, Chief Executive, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
    • Lorraine Nolan, PhD, Vice-Chair of the ICMRA; Chief Executive, Health Products Regulatory Authority (HPRA), Ireland
    • Guido Rasi, MD, Executive Director, European Medicines Agency, European Union
    • Pierre Sabourin, MBA, Assistant Deputy Minister, Health Products and Food Branch, Health Canada
  • Lightning Round – Current and Future Regulatory Issues for Biotechnology and Pharmaceutical Companies in 2017/2018

    10:00-11:30AM | Room N427BC

    Co-Chairs

    • Ian Hudson, MD, PhD, Executive Director, Medicines and Healthcare products Regulatory Agency (MHRA)
    • Sandra Milligan, MD, JD, Head of Regulatory Affairs and Safety, Merck Research Laboratories

    Panelists

    • Dara Corrigan, JD, Acting Deputy Commissioner for Global Regulatory Operations and Policy, FDA
    • Kazuhiko Mori, MSc, Councilor for Pharmaceutical Affairs, Minister’s Secretariat, Ministry of Health, Labour, and Welfare (MHLW), Japan
    • Guido Rasi, MD, Executive Director, EMA, European Union
    • Pierre Sabourin, MBA, Assistant Deputy Minister, Health Products and Food Branch, Health Canada
    • Julio Sánchez y Tépoz, Head, COFEPRIS, Mexico
  • Policy State-of-Play in Washington, DC, and How it Affects Our Drug Development Ecosystem

    11:30AM-12:00PM | Room N427BC

    Speaker

    • Eleanor Dehoney, Vice President of Policy and Advocacy, Research!America
  • Luncheon

    12:00-1:00PM | Room N427BC
  • TransCelerate Update

    1:00-2:00PM | Room N427BC

    Chair

    • Jennifer Burgess, Senior Director, Communications and External Engagement, TransCelerate Biopharma, Inc.

    Panelists

    • Janice Chang, Senior Vice President, Global Operations, TransCelerate Biopharma, Inc.
    • Julian Jenkins, PhD, MSc, Vice President, Innovation Performance and Technology, GlaxoSmithKline
    • Craig Lipset, MBA, Head of Clinical Innovation, Global Product Development, Pfizer Inc.
  • Clinical Research Organizations (CROs) Leadership Round Table: Critical Opportunities and Challenges in Drug Development

    2:00-3:30PM | Room N427BC

    Panelists

    • Michael Kleinrock, Director, Research Development, QuintilesIMS
    • Sudip Parikh, PhD, Senior Vice President and Managing Director, DIA Americas, DIA Small Panel of CRO Discussants

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.